The Efficacy and Safety of Flexible-Dose Vardenafil (Levitra®) in a Broad Population of European Men
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 45 (5) , 634-641
- https://doi.org/10.1016/j.eururo.2004.01.014
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic ProstatectomyJournal of Urology, 2003
- THE POTENTIAL VALUE OF ERECTILE DYSFUNCTION INQUIRY AND MANAGEMENTInternational Journal Of Clinical Practice, 2003
- Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trialUrology, 2003
- Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With DiabetesDiabetes Care, 2003
- Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil usersInternational Journal Of Impotence Research, 2002
- Achieving treatment optimization with sildenafil citrate (Viagra®) in patients with erectile dysfunctionUrology, 2002
- When an erection alone is not enough: biopsychosocial obstacles to lovemakingInternational Journal Of Impotence Research, 2002
- Vardenafil: update on clinical experienceInternational Journal Of Impotence Research, 2002
- Diagnosis and treatment of erectile dysfunctionThe American Journal of Medicine, 2000
- ImpotenceJAMA, 1993